Evidence map›Paper›PMID 40233125›Full record

ArticlePLoS biology2025

Staphylococcal toxin PVL ruptures model membranes under acidic conditions through interactions with cardiolipin and phosphatidic acid.

Seong H Chow, Yusun Jeon, Pankaj Deo, Amy T Y Yeung, Christine Hale, Sushmita Sridhar, Gilu Abraham, Joshua Nickson, Françios A B Olivier, Jhih-Hang Jiang and 12 more

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Seong H ChowDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Yusun JeonDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Pankaj DeoDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Amy T Y YeungThe Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
Christine HaleThe Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
Sushmita SridharThe Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
Gilu AbrahamDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Joshua NicksonDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Françios A B OlivierDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Jhih-Hang JiangDepartment of Microbiology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Yue DingDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Mei-Ling HanDepartment of Microbiology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Anton P Le BrunAustralian Centre for Neutron Scattering, Australian Nuclear Science and Technology Organisation, Kirrawee DC, Australia.
Dovile AndersonDrug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
Darren CreekDrug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
Janette TongDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Kip GabrielDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Jian LiCentre to Impact AMR, Monash University, Clayton, Australia.
Ana TravenDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Gordon DouganThe Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
Hsin-Hui ShenDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
Thomas NadererDepartment of Biochemistry and Molecular Biology, Infection Program, Biomedicine Discovery Institute, Monash University, Clayton, Australia.ORCID https://orcid.org/0000-0003-2691-0283

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Panton-Valentine leukocidin (PVL) is a pore-forming toxin secreted by Staphylococcus aureus strains that cause severe infections. Bicomponent PVL kills phagocytes depending on cell surface receptors, such as complement 5a receptor 1 (C5aR1). How the PVL-receptor interaction enables assembly of the leukocidin complex, targeting of membranes, and insertion of a pore channel remains incompletely understood. Here, we demonstrate that PVL binds the anionic phospholipids, phosphatidic acid, and cardiolipin, under acidic conditions and targets lipid bilayers that mimic lysosomal and mitochondrial membranes, but not the plasma membrane. The PVL-lipid interaction was sufficient to enable leukocidin complex formation as determined by neutron reflectometry and the rupture of model membranes, independent of protein receptors. In phagocytes, PVL and its C5aR1 receptor were internalized depending on sphingomyelin and cholesterol, which were dispensable for the interaction of the toxin with the plasma membrane. Internalized PVL compromised the integrity of lysosomes and mitochondria before plasma membrane rupture. Preventing the acidification of organelles or the genetic loss of PVL impaired the escape of intracellular S. aureus from macrophages. Together, the findings advance our understanding of how an S. aureus toxin kills host cells and provide key insights into how leukocidins target membranes.

Indexed as

Bacterial ToxinsCardiolipinsExotoxinsLeukocidinsPhosphatidic AcidsAnimalsCell MembraneHumansHydrogen-Ion ConcentrationLipid BilayersLysosomesMacrophagesMiceMitochondriaMitochondrial MembranesReceptor, Anaphylatoxin C5aBacterial ToxinsCardiolipinsExotoxinsLeukocidinsLipid BilayersPanton-Valentine leukocidinPhosphatidic AcidsReceptor, Anaphylatoxin C5a

Identifiers

PMID40233125
PMCPMC12052211

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.